<p>The United Kingdom’s NHS &#8212; the world’s largest public health service &#8212; is working on creaking IT infrastructure, doctors tell the Financial Times. “I am at a top London hospital and yet at times I feel as though we are operating in the stone age,” one doctor tells the FT. For example, doctors email lists [&hellip;]</p>

<p>The United Kingdom’s NHS &#8212; the world’s largest public health service &#8212; is working on creaking IT infrastructure, doctors tell the Financial Times. “I am at a top London hospital and yet at times I feel as though we are operating in the stone age,” one doctor tells the FT. For example, doctors email lists [&hellip;]</p>

<p>When you think of brain-stimulating medtech, startups building wearables as therapeutics probably aren&#8217;t the first thing that springs to mind. Such tech is still flying fairly under the radar &#8212; perhaps, in part, because these sorts of companies have raised a fraction of the investment that’s been ploughed into invasive technologies for targeting treatments at [&hellip;]</p>

<p>In January last year, German biotech company BioNTech acquired African AI startup InstaDeep for over $550 million, a deal finalized in July of the same year. InstaDeep, whose exit is currently the largest from Africa, has been operating under the German pharma umbrella for just over a year. Now is a good time to look [&hellip;]</p>

<p>In January last year, German biotech company BioNTech acquired African AI startup InstaDeep for over $550 million, a deal finalized in July of the same year. InstaDeep, whose exit is currently the largest from Africa, has been operating under the German pharma umbrella for just over a year. Now is a good time to look [&hellip;]</p>

<p>The wearables category already contains multitudes, from exercise-focused smart watches and sleep-tracking smart rings to smart women&#8217;s health tech and semi-invasive blood glucose monitors &#8212; to name a few of the gizmos we&#8217;ve tracked over roughly a decade of novel personal hardware launches. But the space is set to get even more active, with a [&hellip;]</p>

<p>The wearables category already contains multitudes, from exercise-focused smart watches and sleep-tracking smart rings to smart women&#8217;s health tech and semi-invasive blood glucose monitors &#8212; to name a few of the gizmos we&#8217;ve tracked over roughly a decade of novel personal hardware launches. But the space is set to get even more active, with a [&hellip;]</p>

<p>As well as being a major cause of premature death worldwide, hypertension, also known as high blood pressure, is a major risk factor for stroke, coronary artery disease, and heart failure, and is a contributing factor to dementia. It also affects an estimated 1.3 billion people; up to 95% of cases are due to lifestyle [&hellip;]</p>

<p>Advances in DNA sequencing and the vast amounts of genomic data being produced by next-generation sequencing (NGS) technology have created a startup opportunity to build software for biologists so they can more easily analyze this big data and take the next leap. It could help when it comes to developing new vaccines, cancer treatments, and [&hellip;]</p>

<p>The synthetic biology and precision fermentation space is a hotbed of entrepreneurial activity these days. But it&#8217;s not every day you come across a startup that&#8217;s using genetic engineering to produce natural rubber — a substance that&#8217;s challenging to reproduce in a lab because of how long its polymer is. Paris-based baCta has a proof [&hellip;]</p>

<p>Amazon Pharmacy is expanding its same-day delivery service to 20 more U.S. cities next year, the company announced on Wednesday. Amazon says the expansion will more than double the number of cities where customers can get same-day delivery of their medications. As part of the expansion, Amazon is opening new pharmacies that will include Amazon [&hellip;]</p>

<p>While companies like OpenAI and Anthropic continue to popularize the idea of using ordinary language to ask artificial intelligence agents for answers to their questions, write their proposals or draw pictures, a London startup called Basecamp Research has raised $60 million to tackle a new frontier. It&#8217;s building an AI agent that not only answers [&hellip;]</p>

<p>French biotech startup Generare has closed a €5 million seed round (around $5.5 million at current exchange rates) to step up development of what it touts as a highly scalable approach to identifying promising compounds for drug discovery that already exist in nature. It&#8217;s focused on sifting for molecules that are produced by microorganisms but [&hellip;]</p>

<p>Customers of genetic data outfit 23andMe may be at greater risk than they realize, suggests a New York Times story that argues the company’s woes could be short-lived compared to the longer-term threats facing those roughly 15 million people if 23andMe can’t continue as a going concern. Certainly, the hope of founder and CEO Anne [&hellip;]</p>

<p>Customers of genetic data outfit 23andMe may be at greater risk than they realize, suggests a New York Times story that argues the company’s woes could be short-lived compared to the longer-term threats facing those roughly 15 million people if 23andMe can’t continue as a going concern. Certainly, the hope of founder and CEO Anne [&hellip;]</p>

<p>A group of major medical institutions specializing in cancer care have formed a partnership to better take advantage of AI&#8217;s potential to advance the space. With $40 million of cash and resources from big tech backers, the Cancer AI Alliance (CAIA) could be a huge step forward in precision medicine. The members of the alliance [&hellip;]</p>

<p>A group of major medical institutions specializing in cancer care have formed a partnership to better take advantage of AI&#8217;s potential to advance the space. With $40 million of cash and resources from big tech backers, the Cancer AI Alliance (CAIA) could be a huge step forward in precision medicine. The members of the alliance [&hellip;]</p>

<p>The offices of plant-based protein startup Heura are tucked away down a narrow street a short distance from one of Barcelona&#8217;s main tourist draws. But the team of entrepreneurs and food scientists won&#8217;t be remixing their protein cocktails in close proximity to La Sagrada Família for much longer &#8212; they&#8217;re moving to new, larger digs [&hellip;]</p>

<p>The offices of plant-based protein startup Heura are tucked away down a narrow street a short distance from one of Barcelona&#8217;s main tourist draws. But the team of entrepreneurs and food scientists won&#8217;t be remixing their protein cocktails in close proximity to La Sagrada Família for much longer &#8212; they&#8217;re moving to new, larger digs [&hellip;]</p>

<p>Air Doctor&#8217;s platform helps travelers find doctors in other countries, and it has now raised $20 million in a Series B round after seeing strong traction. </p>